| Announce Date | 11/19/2025 |
| EPS Normalized Actual | $3.06 (Beat by $0.09) |
| EPS GAAP Actual | $3.06 (Beat by $0.09) |
| Revenue Actual | $20.813B |
| Revenue Surprise | Beat by $20813M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2030 | 19.3 | 14.89 | 18.94579 | 19.84845 | 4 |
| Feb 2029 | 18.435 | 15.59 | 17.74142 | 18.88378 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.88 | 2.88 | 20.813B | 3.09% | 20813M |
| FQ3 2025 (Aug 2025) | 4.28 | 4.28 | 23.959B | 100% | 23959M |
| FQ2 2025 (May 2025) | 2.93 | 2.93 | 20.93B | 100% | 20930M |
| FQ1 2025 (Jan 2025) | 2 | 2 | 18.553B | 100% | 18553M |
| FQ4 2024 (Nov 2024) | 2.98 | 2.98 | 20.17B | 100% | 20170M |
| FQ3 2023 (Jul 2023) | 4.56 | 4.56 | 24.956B | -10.1% | 24956M |
| FQ2 2023 (Apr 2023) | 3.78 | 3.78 | 22.347B | -5.87% | 22347M |
| FQ2 2022 (Apr 2022) | 3.53 | 3.53 | 23.659B | 100% | 23659M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 3.8116 | -- | 3.6507 | 3.88976 | 11 |
| FQ3 2028 (Jul 2028) | 5.2067 | -- | 4.98691 | 5.31347 | 11 |
| FQ2 2028 (Apr 2028) | 3.6416 | -- | 3.48788 | 3.71627 | 10 |
| FQ1 2028 (Feb 2028) | 2.58591 | -- | 2.51653 | 2.64281 | 9 |
| FQ4 2027 (Oct 2027) | 3.71 | -- | 3.67536 | 3.8901 | 13 |
| FQ3 2027 (Jul 2027) | 4.92 | -- | 4.87407 | 5.15884 | 17 |
| FQ2 2027 (Apr 2027) | 3.53 | -- | 3.45943 | 3.61922 | 10 |
| FQ1 2027 (Jan 2027) | 2.2916 | -- | 2.2353 | 2.33832 | 16 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 19.91B | -- | 19.26B | 20.22B | 6 |
| FQ3 2028 (Jul 2028) | 19.98B | -- | 19.34B | 20.3B | 8 |
| FQ2 2028 (Apr 2028) | 20.06B | -- | 19.41B | 20.37B | 6 |
| FQ1 2028 (Feb 2028) | 20.75B | -- | 20.32B | 21.1B | 14 |
| FQ4 2027 (Oct 2027) | 21.76B | -- | 21.6B | 22.57B | 24 |
| FQ3 2027 (Jul 2027) | 25.22B | -- | 25.04B | 26.16B | 21 |
| FQ2 2027 (Apr 2027) | 22.39B | -- | 22.04B | 22.82B | 10 |
| FQ1 2027 (Jan 2027) | 20.2B | -- | 19.82B | 20.52B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.88 | 2.88 | 100% | |
| FQ3 2025 (Aug 2025) | 4.28 | 4.28 | 100% | |
| FQ2 2025 (May 2025) | 2.93 | 2.93 | 100% | |
| FQ1 2025 (Jan 2025) | 2 | 2 | 100% | |
| FQ4 2024 (Nov 2024) | 2.98 | 2.98 | 100% | |
| FQ3 2023 (Jul 2023) | 4.56 | 4.56 | 100% | |
| FQ2 2023 (Apr 2023) | 3.78 | 3.78 | 100% | |
| FQ2 2022 (Apr 2022) | 3.53 | 3.53 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $20.81B | $20813M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $23.96B | $23959M | 100% |
| FQ2 2025 (May 2025) | $0B | $20.93B | $20930M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $18.55B | $18553M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $20.17B | $20170M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $24.96B | $24956M | 100% |
| FQ2 2023 (Apr 2023) | $0B | $22.35B | $22347M | 100% |
| FQ2 2022 (Apr 2022) | $0B | $23.66B | $23659M | 100% |